Price $53.60 |
Market Cap
3.01B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
70.9
|
P/B
3.23
|
P/S
3.55
|
Dividend %
-
|
|
P/CF
103.1
|
P/FCF
37.3
|
Op. Cash Flow
82.2K
|
FCF
1.5
|
|
Op. Margin
7.00%
|
Net Margin
4.70%
|
ROE
5.30%
|
ROI
4.00%
|
|
ROA
3.20%
|
EPS Growth
24.50%
|
Current Ratio
2.7
|
Debt/Equity
38.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $160.22 | - | 2.20% | 44.79B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.54 | - | - | 66.1M | Strong Buy |
| Integer Holdings Corp (ITGR) | $80.67 | - | - | 2.46B | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.09 | - | - | 6.58B | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $1.42 | - | - | 13.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
